Evaluation of pre- and post-fusion Human metapneumovirus F proteins as subunit vaccine candidates in mice

Vaccine. 2020 Feb 24;38(9):2122-2127. doi: 10.1016/j.vaccine.2020.01.047. Epub 2020 Jan 29.

Abstract

Human metapneumovirus (hMPV) is an important respiratory pathogen especially in young children and elderly subjects. Our objective was to assess the immunogenicity and protection conferred by predominant pre- and post-fusion (F) hMPV-F constructs in Balb/C mice. Immunizations without adjuvant were not immunogenic whereas alum-adjuvanted hMPV-F proteins, regardless of their conformations, generated comparable neutralizing antibody titers with undetectable pulmonary viral titers following viral challenge. In conclusion, we found no apparent advantage for mixtures of predominant pre-fusion F proteins over post-fusion conformations for hMPV vaccination in opposite to recent data obtained with the human respiratory syncytial virus.

Keywords: Balb/C; Fusion protein; Immunisation; Pre-fusion; Vaccine; hMPV.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic / administration & dosage*
  • Animals
  • Antibodies, Neutralizing / blood
  • Antibodies, Viral / blood
  • Metapneumovirus* / immunology
  • Mice
  • Mice, Inbred BALB C
  • Paramyxoviridae Infections* / prevention & control
  • Vaccines, Subunit / immunology
  • Viral Fusion Proteins / administration & dosage
  • Viral Fusion Proteins / immunology*
  • Viral Vaccines / immunology*

Substances

  • Adjuvants, Immunologic
  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Vaccines, Subunit
  • Viral Fusion Proteins
  • Viral Vaccines